Literature DB >> 32062550

RNA-based pharmacotherapy for tumors: From bench to clinic and back.

Xiangping Liang1, Dongpei Li2, Shuilong Leng3, Xiao Zhu4.   

Abstract

RNA therapy is a treatment that regulates cell proteins and cures diseases by affecting the metabolism of mRNAs in cells, which has cut a figure in the studies on various incurable illnesses like hereditary diseases, tumors, etc. In this review, we introduced the discovery and development of RNA therapy and discussed its classification, mechanisms, advantages, and challenges. Moreover, we highlighted how RNA therapy works in killing tumor cells as well as what progresses it has made in related researches. And the development of RNA anti-tumor drugs and the clinical trial process were also included.
Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Cancer immunotherapy; Clinical trials; RNA drugs; RNA therapy

Mesh:

Substances:

Year:  2020        PMID: 32062550     DOI: 10.1016/j.biopha.2020.109997

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  15 in total

1.  Three-dimensional genome: developmental technologies and applications in precision medicine.

Authors:  Yingqi Li; Tao Tao; Likun Du; Xiao Zhu
Journal:  J Hum Genet       Date:  2020-03-09       Impact factor: 3.172

Review 2.  The clinical progress of mRNA vaccines and immunotherapies.

Authors:  Ann J Barbier; Allen Yujie Jiang; Peng Zhang; Richard Wooster; Daniel G Anderson
Journal:  Nat Biotechnol       Date:  2022-05-09       Impact factor: 68.164

Review 3.  RNA-based therapies: A cog in the wheel of lung cancer defense.

Authors:  Parvez Khan; Jawed Akhtar Siddiqui; Imayavaramban Lakshmanan; Apar Kishor Ganti; Ravi Salgia; Maneesh Jain; Surinder Kumar Batra; Mohd Wasim Nasser
Journal:  Mol Cancer       Date:  2021-03-19       Impact factor: 27.401

Review 4.  Modulating the Crosstalk between the Tumor and Its Microenvironment Using RNA Interference: A Treatment Strategy for Hepatocellular Carcinoma.

Authors:  Mariam Mroweh; Thomas Decaens; Patrice N Marche; Zuzana Macek Jilkova; Flora Clément
Journal:  Int J Mol Sci       Date:  2020-07-24       Impact factor: 5.923

5.  Clinical and Prognostic Pan-Cancer Analysis of N6-Methyladenosine Regulators in Two Types of Hematological Malignancies: A Retrospective Study Based on TCGA and GTEx Databases.

Authors:  Xiangsheng Zhang; Liye Zhong; Zhilin Zou; Guosheng Liang; Zhenye Tang; Kai Li; Shuzhen Tan; Yongmei Huang; Xiao Zhu
Journal:  Front Oncol       Date:  2021-03-18       Impact factor: 6.244

Review 6.  RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics.

Authors:  Poonam R Pandey; Ken H Young; Dhiraj Kumar; Neeraj Jain
Journal:  Mol Cancer       Date:  2022-02-21       Impact factor: 27.401

Review 7.  Long Non-Coding RNAs as Functional Codes for Oral Cancer: Translational Potential, Progress and Promises.

Authors:  Cing-Syuan Lei; Hsing-Jien Kung; Jing-Wen Shih
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

Review 8.  Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope.

Authors:  Fatah Kashanchi; Reza Jafari; Cynthia Aslan; Seyed Hossein Kiaie; Naime Majidi Zolbanin; Parisa Lotfinejad; Reihaneh Ramezani
Journal:  BMC Biotechnol       Date:  2021-03-10       Impact factor: 2.563

Review 9.  Intracellular Routing and Recognition of Lipid-Based mRNA Nanoparticles.

Authors:  Christophe Delehedde; Luc Even; Patrick Midoux; Chantal Pichon; Federico Perche
Journal:  Pharmaceutics       Date:  2021-06-24       Impact factor: 6.321

Review 10.  Mesenchymal stem cells: ideal seeds for treating diseases.

Authors:  Guanwen Gao; Chenyang Fan; Weiquan Li; Runzhang Liang; Chuzhong Wei; Xiaojie Chen; Yue Yang; Yueyuan Zhong; Yingqi Shao; Yi Kong; Zesong Li; Xiao Zhu
Journal:  Hum Cell       Date:  2021-07-16       Impact factor: 4.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.